Funding · Company
VEDANTA BIOSCIENCES, INC.
Cambridge, MABiotech & Pharma
VEDANTA BIOSCIENCES, INC. of Cambridge, MA has disclosed $187M across 2 Form D offerings filed with the SEC between Aug 13, 2021 and Aug 5, 2024.
$187M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$119M
Form D · Aug 5, 2024 ↗
Q3 2024
· 1 amendment, first filed May 2, 2023
$68M
Form D · Aug 13, 2021 ↗
Q3 2021
· target $75M
Filing details
HeadquartersCambridge, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001677878Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →